References and Notes
<A NAME="RG33408ST-1A">1a</A>
Perregaard J.
Andersen K.
Hyttel J.
Sánchez C.
J.
Med. Chem.
1992,
35:
4813
<A NAME="RG33408ST-1B">1b</A>
Zhang H.-C.
Derian
CK.
McComsey DF.
White KB.
Ye H.
Hecker
LR.
Li J.
Addo MF.
Croll D.
Eckardt AJ.
Smith
CE.
Li Q.
Cheung W.-M.
Conway BR.
Emanuel S.
Demarest KT.
Andrade-Gordon P.
Damiano BP.
Maryanoff BE.
J.
Med. Chem.
2005,
48:
1725
<A NAME="RG33408ST-1C">1c</A>
Xu H.
Liu W.-Q.
Fan L.-L.
Chen Y.
Yang L.-M.
Lv L.
Zheng Y.-T.
Chem. Pharm.
Bull.
2008,
56:
720
<A NAME="RG33408ST-2A">2a</A>
Pallos FM, and
Mathews CJ. inventors; WO 9315049.
; Chem. Abstr. 1993, 120, 8470
<A NAME="RG33408ST-2B">2b</A> . inventors; EP 1783114.
; Chem. Abstr. 2007, 146, 500886
<A NAME="RG33408ST-3">3</A>
Ley SV.
Thomas AW.
Angew. Chem. Int.
Ed.
2003,
42:
5400
<A NAME="RG33408ST-4">4</A>
Old DW.
Harris MC.
Buchwald SL.
Org. Lett.
2000,
2:
1403
<A NAME="RG33408ST-5A">5a</A>
Lindley J.
Tetrahedron
1984,
40:
1433
<A NAME="RG33408ST-5B">5b</A>
Beletskaya IP.
Cheparov AV.
Coord.
Chem. Rev.
2004,
248:
2337
<A NAME="RG33408ST-6">6</A>
Antilla JC.
Klapars A.
Buchwald SL.
J.
Am. Chem. Soc.
2002,
124:
11684
<A NAME="RG33408ST-7A">7a</A>
Gujadhur RK.
Bates CG.
Venkataraman D.
Org. Lett.
2001,
3:
4315
<A NAME="RG33408ST-7B">7b</A>
Van Allen D.
Venkataraman D.
J.
Org. Chem.
2003,
68:
4590
<A NAME="RG33408ST-7C">7c</A>
Tang B.-X.
Guo S.-M.
Zhang M.-B.
Li J.-H.
Synthesis
2008,
1707
<A NAME="RG33408ST-8A">8a</A>
Ma D.
Cai Q.
Synlett
2004,
128
<A NAME="RG33408ST-8B">8b</A>
Cai Q.
Zhu W.
Zhang H.
Zhang Y.
Ma D.
Synthesis
2005,
496
<A NAME="RG33408ST-9">9</A>
Cristau H.-J.
Cellier PP.
Spindler J.-F.
Taillefer M.
Chem. Eur. J.
2004,
10:
5607
<A NAME="RG33408ST-10">10</A>
Huang Y.-Z.
Miao H.
Zhang Q.-H.
Chen C.
Xu J.
Catal.
Lett.
2008,
122:
344
<A NAME="RG33408ST-11">11</A>
Correa A.
Bolm C.
Adv. Synth. Catal.
2007,
349:
2673
<A NAME="RG33408ST-12">12</A>
Analytical Data
of 1-(Pyridin-2-yl)-1
H
-indole-3-carboxaldehyde (2a)
Mp
114-115 ˚C (MeOH). IR (KBr): 3101, 3050,
2821, 1667, 1649, 1593, 1579, 1539, 1471, 1455, 1444, 1224, 1128,
1083, 739 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 7.33-7.43
(m, 3 H, H-5, H-5′, H-6), 7.64 (d, 1 H, J = 8.3 Hz,
H-3′), 7.95 (td, 1 H, J = 1.9,
7.7 Hz, H-4′), 8.02-8.05 (m, 1 H, H-4 or H-7),
8.38 (s, 1 H, H-2), 8.38-8.41 (m, 1 H, H-4 or H-7), 8.64
(dd, 1 H, J = 1.3,
4.7 Hz, H-6′), 10.16 (s, 1 H, CHO). ¹³C
NMR (75 MHz, CDCl3): δ = 112.8
(CH), 115.7 (CH), 120.5 (C), 122.2 (CH), 122.3 (CH), 123.8 (CH),
125.1 (CH), 126.3 (C), 136.2 (C), 137.0 (CH), 139.0 (CH), 149.4 (CH),
150.9 (C), 185.4 (CO). ESI-MS: m/z = 223 [M + H]+. Anal.
Calcd for C14H10N2O: C, 75.66;
H, 4.54; N, 12.60. Found: C, 75.99; H, 4.32; N, 12.55.
<A NAME="RG33408ST-13">13</A>
Analytical Data
of 1,2-Di(pyridin-2-yl)-1
H
-indole-3-carboxaldehyde (3a)
Mp
127-128 ˚C (EtOAc-PE). IR (KBr):
3051, 3012, 2831, 1648, 1443, 1387, 1050, 754, 741 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 7.19
(d, 1 H, J = 7.9
Hz, H-3′ or H-3′′), 7.27-7.44
(m, 5 H, H-3′ or H-3′′, H-5, H-5′,
H-5′′, H-6), 7.54 (d,
1 H, J = 7,4 Hz,
H-4 or H-7), 7.67-7.79 (m, 2 H, H-4′, H-4′′), 8.53-8.60
(m, 3 H, H-4 or H-7, H-6′, H-6′′), 10.18
(s, 1 H, CHO). ¹³C NMR (75 MHz, CDCl3): δ = 111.4
(CH), 117.7 (C), 122.1 (CH), 122.7 (CH), 123.1 (CH), 123.6 (CH),
124.0 (CH), 125.3 (CH), 125.4 (C), 126.8 (CH), 136.3 (CH), 137.4 (C),
138.4 (CH), 147.3 (C), 148.8 (C), 149.6 (CH), 149.9 (CH), 150.4
(C), 187.8 (CO). ESI-MS: m/z = 300 [M + H]+. Anal.
Calcd for C19H13N3O: C, 76.24;
H, 4.38; N, 14.04. Found: C, 76.34; H, 4.43; N, 13.96.
<A NAME="RG33408ST-14">14</A>
Seki K.
Ohkura K.
Terashima M.
Kanaoka Y.
Heterocycles
1994,
37:
993
<A NAME="RG33408ST-15">15</A>
Typical Procedure
In
a sealed tube, a solution of 2a (100 mg,
0.45 mmol, 1 equiv), Cu2O (6.5 mg, 0.045 mmol, 0.1 equiv),
2-iodo-pyridine (101 µL, 0.90 mmol, 2 equiv), and K2CO3 (124
mg, 0.90 mmol, 2 equiv) in anhyd DMF (0.9 mL) was stirred at 153 ˚C
for 3 d. The reaction was cooled to r.t., filtered through Celite,
and the filtrate was concentrated in vacuo. The residue was diluted
in EtOAc (20 mL). The organic layer was washed with a solution of
2.5% aq NH4OH (2 × 20 mL)
and brine (20 mL). The organic phase was dried over MgSO4,
filtered, and concentrated in vacuo. The crude product was purified
by flash column chromatography (PE-EtOAc,
2:8 to 1:1) to provide 3a (110 mg, 84%).
<A NAME="RG33408ST-16A">16a</A>
Lane SS.
Sames D.
Org.
Lett.
2004,
6:
2897
<A NAME="RG33408ST-16B">16b</A>
Lane BS.
Brown MA.
Sames D.
J. Am. Chem. Soc.
2005,
127:
8050
<A NAME="RG33408ST-16C">16c</A>
Toure BB.
Lane BS.
Sames D.
Org. Lett.
2006,
8:
1979
<A NAME="RG33408ST-16D">16d</A>
Bellina F.
Cauteruccio S.
Rossi R.
Eur.
J. Org. Chem.
2006,
1379
<A NAME="RG33408ST-16E">16e</A>
Bellina F.
Calandri C.
Cauteruccio S.
Rossi R.
Tetrahedron
2007,
63:
1970
<A NAME="RG33408ST-16F">16f</A>
Wang X.
Gribkov DV.
Sames D.
J.
Org. Chem.
2007,
72:
1476
<A NAME="RG33408ST-16G">16g</A>
Lebrasseur N.
Larrosa I.
J. Am. Chem. Soc.
2008,
130:
2926
<A NAME="RG33408ST-16H">16h</A>
Alberico D.
Scott ME.
Lautens M.
Chem.
Rev.
2007,
107:
174
<A NAME="RG33408ST-17">17</A>
Wang X.
Lane BS.
Sames D.
J.
Am. Chem. Soc.
2005,
127:
4996
<A NAME="RG33408ST-18">18</A>
Phipps RJ.
Grimster NP.
Gaunt MJ.
J. Am. Chem. Soc.
2008,
130:
8172
<A NAME="RG33408ST-19">19</A>
Analytical Data
of 2-Phenyl-1-(pyridin-2-yl)-1
H
-indole-3-carboxaldehyde (3b)
²6
Mp 171-172 ˚C
(EtOAc-PE). IR (KBr): 3065, 3043, 2836, 1652, 1466, 1454,
1384, 1225, 1082, 756 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 6.94
(d, 1 H, J = 7.9
Hz, H-3′), 7.30-7.43 (m, 8 H, H-5, H-5′,
H-6, Harom), 7.51 (d, 1 H, J = 7.5
Hz, H-4 or H-7), 7.68 (td, 1 H, J = 1.9,
8.0 Hz, H-4′), 8.50 (br d, 1 H, J = 6.9
Hz, H-4 or H-7), 8.65 (dd, 1 H, J = 1.3,
4.9 Hz, H-6′), 9.97 (s, 1 H, CHO). ¹³C
NMR (75 MHz, CDCl3): δ = 111.6
(CH), 116.9 (C), 122.2 (CH), 122.4 (CH), 123.2 (CH), 123.9 (CH),
124.8 (CH), 125.5 (C), 128.5 (2 CH), 128.8 (C), 129.5 (CH), 131.1
(2 CH), 137.5 (C), 138.3 (CH), 149.6 (CH), 149.9 (C), 150.2 (C),
187.6 (CO). ESI-MS: m/z = 299 [M + H]+.
Anal. Calcd for C20H14N2O: C 80.52;
H, 4.73; N, 9.39. Found: C, 80.83; H, 4.85; N, 9.27.
<A NAME="RG33408ST-20">20</A>
Analytical Data
of 1-(Pyridin-2-yl)-2-(4-methylphenyl)-1
H
-indole-3-carboxaldehyde (3f)
Mp
206-207 ˚C (EtOAc-PE). IR (KBr):
3048, 2916, 2836, 1642, 1435, 1081, 747, 737 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 2.37
(s, 3 H, CH3), 6.92 (d, 1 H, J = 6.9
Hz,
H-3′), 7.15 (d, 2 H, J = 8.0
Hz, Harom), 7.26 (d, 2 H, J = 8.0 Hz,
Harom), 7.29-7.41 (m, 3 H, H-5, H-5′,
H-6), 7.50 (dd, 1 H, J = 0.9,
7.4 Hz, H-4 or H-7), 7.68 (td, 1 H, J = 1.9,
7.7 Hz, H-4′), 8.48 (dd, 1 H, J = 1.1,
7.3 Hz, H-4 or H-7), 8.65 (dd, 1 H, J = 1.1,
4.9 Hz, H-6′), 9.95 (s, 1 H, CHO). ¹³C
NMR (75 MHz, CDCl3): δ = 21.4
(CH3), 111.5 (CH), 116.7 (C), 122.1 (CH), 122.5 (CH),
123.1 (CH), 123.8 (CH), 124.7 (CH), 125.5 (C), 125.8 (C), 129.2
(2 CH), 131.0 (2 CH), 137.5 (C), 138.3 (CH), 139.7 (C), 149.6 (CH),
150.2 (C), 150.3 (C), 187.6 (CO). ESI-MS: m/z = 313 [M + H]+.
Anal. Calcd for C21H16N2O: C, 80.75,
H, 5.16; N, 8.97. Found: C, 8.48; H, 4.97; N, 9.03.
<A NAME="RG33408ST-21">21</A>
Kantam ML.
Yadav J.
Laha S.
Sreedhar B.
Jha S.
Adv. Synth.
Catal.
2007,
349:
1938
<A NAME="RG33408ST-22">22</A>
Seki K.
Ohkura K.
Terashima M.
Kanaoka Y.
Heterocycles
1987,
26:
3101
<A NAME="RG33408ST-23">23</A>
Analytical Data
of 1-(Pyridin-2-yl)-1
H
-indole-3-carbonitrile (11e)
Mp
150-151 ˚C (MeOH). IR (KBr): 3135, 3050,
2222, 1592, 1540, 1473, 1455, 1434, 1229, 1095, 735 cm-¹. ¹H NMR
(300 MHz, CDCl3): δ = 7.32-7.45
(m, 3 H, H-5, H-5′, H-6), 7.56 (d, 1 H, J = 8.1
Hz, H-3′), 7.83 (br d, 1 H, J = 7.5 Hz,
H-4 or H-7), 7.93 (td, 1 H, J = 1.9,
7.5 Hz, H-4′), 8.10 (br d, 1 H, J = 7.1
Hz, H-4 or H-7), 8.23 (s, 1 H, H-2), 8.63 (dd, 1 H, J = 1.1, 4.9
Hz, H-6′). ¹³C NMR (75 MHz,
CDCl3): δ = 89.8
(C), 113.4 (CH), 115.3 (C), 115.6 (CH), 120.0 (CH), 122.3 (CH),
123.4 (CH), 125.2 (CH), 128.7 (C), 133.3 (CH), 134.4 (C), 139.1
(CH), 149.5 (CH), 150.7 (C). ESI-MS: m/z = 220 [M + H]+.
Anal. Calcd for C14H9N3: C, 76.70, H,
4.14, N, 19.17. Found: C, 76.72; H, 4.08; N, 19.25.
<A NAME="RG33408ST-24">24</A>
Analytical Data
of 1,2-Di(pyridin-2-yl)-1
H
-indole-3-carbonitrile (11d)
Mp
128-129 ˚C (CH2Cl2-PE).
IR (KBr): 3065, 2213, 1589, 1569, 1467, 1448, 1435, 1393, 1225,
738 cm-¹. ¹H NMR (300
MHz, CDCl3): δ = 7.24-7.41
(m, 5 H, H-3′ or H-3′′,
H-5,
H-5′, H-5′′, H-6), 7.50-7.53
(m, 1 H, H-4 or H-7), 7.82-7.89 (m, 4 H, H-3′ or
H-3′′, H-4 or H-7, H-4′, H-4′′),
8.44 (br d, 1 H, J = 4.1
Hz, H-6′or H-6′′), 8.51 (dd, 1 H, J = 1.1, 4.7, H-6′ or
H-6′′). ¹³C NMR (75
MHz, CDCl3): δ = 89.3
(C), 112.1 (CH), 116.1 (C), 120.0 (CH), 122.0 (CH), 123.1 (CH), 123.4
(CH), 123.5 (CH), 124.9 (CH), 125.5 (CH), 127.6 (C), 136.8 (CH),
137.2 (C), 138.4 (CH), 144.8 (C), 148.2 (C), 149.5 (CH), 149.6 (CH),
150.7 (C). ESI-MS: m/z = 297 [M + H]+.
Anal. Calcd for C19H12N4: C, 77.01,
H, 4.08, N, 18.91. Found: C, 76.88; H, 4.27; N, 19.01.
<A NAME="RG33408ST-25">25</A>
Typical Procedure
In
a microwave vial with a magnetic stir bar was introduced indole-3-carboxaldehyde
(100 mg, 0.68 mmol, 1 equiv), Cu2O (10 mg, 0.07 mmol,
0.1 equiv), and K2CO3 (189 mg, 1.36 mmol,
2 equiv) in anhyd DMF (1.4 mL). After a purge with argon, 2-iodopyridine
(153 µL, 1.36 mmol, 2 equiv) was added. The vial was sealed
and heated at 240 ˚C under microwave irradiation
(Biotage Initiator) for 1 h. The mixture was filtered through Celite,
and the filtrate was concentrated in vacuo. The residue was diluted
in EtOAc (20 mL). The organic layer was washed with a solution of
2.5% aq NH4OH (2 × 20
mL) and brine (20 mL). The organic phase was dried over MgSO4,
filtered, and concentrated in vacuo. The crude residue was purified
by flash chromatography (PE-EtOAc, 2:8 to 1:1) to provide 2a (88 mg, 58%) and 3a (73 mg, 36%).
<A NAME="RG33408ST-26A">26a</A>
Fernandez I.
Galvez C.
Urpi L.
An. Quim.
1991,
87:
936
<A NAME="RG33408ST-26B">26b</A>
Maassarani F.
Pfeffer M.
Spencer J.
Wehman E.
J. Organomet. Chem.
1994,
466:
265